Exam Details

  • Exam Code
    :RAC-US
  • Exam Name
    :Regulatory Affairs Certification (RAC) US
  • Certification
    :RAPS Certifications
  • Vendor
    :RAPS
  • Total Questions
    :100 Q&As
  • Last Updated
    :May 14, 2024

RAPS RAPS Certifications RAC-US Questions & Answers

  • Question 21:

    Which of the following is NOT required to be included in a marketing application?

    A. Final printed label

    B. Quality, safety, and efficacy Information

    C. Administrative forms

    D. Evidence of fee payment

  • Question 22:

    What is the LAST stage in the development of a quality risk management process for a medical device?

    A. Risk analysis

    B. Risk reduction

    C. Risk acceptance

    D. Risk evaluation

  • Question 23:

    A clinical study of a drug is completed to support a marketing approval application. According to ICH,how long should a sponsor retain the clinical study essential documents?

    A. For at least two years after the last approval of an application in an ICH region

    B. Fora minimum of 10 years after completion of the clinical study

    C. Three years after the last clinical study site was supplied with investigational drugs

    D. Until the product has been discontinued from marketing in all ICH regions

  • Question 24:

    A drug product presents degradation during the manufacturing process. In addition to the amount, what information should be provided FIRST in order to use API overage?

    A. Specification

    B. Formulation

    C. Property

    D. Justification

  • Question 25:

    Why is it necessary to run supplemental safety pharmacology studies?

    A. To substitute the utilization of GLP

    B. To comply with regulatory authority requirements related to clinical studies

    C. To evaluate potential adverse pharmacodynamics effects not addressed by the core battery

    D. To provide adverse reaction reports and the results of the statistical data to the regulatory authority

  • Question 26:

    An inspection of a manufacturing site determines that a number of manufacturing changes have been implemented without obtaining the necessary regulatory clearance. Which of the following actions should the regulatory affairs professional complete FIRST?

    A. Stop product manufacturing.

    B. Establish validation procedures.

    C. Assess the impact of the changes.

    D. Review the stability data for the changes.

  • Question 27:

    The regulatory authority in Country X issued a request for a mandatory product recall in Country X due to serious injuries to patients. This product also is distributed in Country Y.

    What should the regulatory affairs professional of the product's manufacturer FIRST do in Country Y?

    A. Draft a formal letter to customers in Country Y about this recall.

    B. Initiate a mandatory recall of the product in Country Y.

    C. Review alt distribution records and complaints reported in Country Y.

    D. Prepare the legal team in Country Y for possible litigations.

  • Question 28:

    Which of the following is the BEST approach for mitigating potential regulatory compliance issues at your company?

    A. Document any failure to follow regulatory compliance processes in employee performancereviews.

    B. Develop documented procedures for regulatory compliance processes and train personnel.

    C. Train all new employees on regulatory compliance processes and assign a mentor to them.

    D. Train employees on all regulatory compliance processes using state-of-the-art systems.

  • Question 29:

    During routine surveillance, a regulatory authority sent a company the following communication: "Hepatotoxicity and suicidal behavior were identified as potential safety issues for the company's product. The regulatory authority is evaluating these issues to determine the need for any regulatory action." Which action would be the most appropriate FIRST step for the company to take?

    A. Contact the regulatory authority to argue that its conclusions are wrong.

    B. Contact the regulatory authority to discuss its findings.

    C. Repeat the Hepatotoxicity tests and send the results to the regulatory authority.

    D. Wait for the regulatory authority's final publication on its findings.

  • Question 30:

    In a distribution contract for high-risk medical devices, which of the following regulatory requirements is the MOST important for the distributor?

    A. Local reimbursement requirements

    B. Service operation procedures

    C. Training program for sales people

    D. Written procedure for product traceability

Tips on How to Prepare for the Exams

Nowadays, the certification exams become more and more important and required by more and more enterprises when applying for a job. But how to prepare for the exam effectively? How to prepare for the exam in a short time with less efforts? How to get a ideal result and how to find the most reliable resources? Here on Vcedump.com, you will find all the answers. Vcedump.com provide not only RAPS exam questions, answers and explanations but also complete assistance on your exam preparation and certification application. If you are confused on your RAC-US exam preparations and RAPS certification application, do not hesitate to visit our Vcedump.com to find your solutions here.